Literature DB >> 35059236

Antioxidant and lipid-reducing effects of Rosa rugosa root extract in 3T3-L1 cell.

Da-Hye Choi1, Joon-Hee Han1, Min Hong1, Sun-Yeop Lee1, Soo-Ung Lee1, Tae-Hyung Kwon1.   

Abstract

Rosa rugosa root is traditionally known to be effective in the treatment of diabetes in Korea. R. rugosa root-specific compounds also show antioxidant effects, and could reduce lipid and fat accumulation, however, the underlying mechanism has not been clarified. In present study, the antioxidant and lipid-reducing effects of a 50% ethanol extract of R. rugosa (REE) were investigated differentiated mouse preadipocytes (3T3-L1 cells). REE showed strong radical scavenging activities and inhibitory effect of total lipid accumulation and triglyceride levels in differentiated 3T3-L1 cells. In addition, REE treatment reduced the mRNA and protein levels of adipogenesis and lipogenesis markers. This REE-promoted lipid reduction was caused by downregulation of peroxisome proliferator activated receptor gamma (PPARγ), CCAAT/enhancer binding protein alpha (C/EBPα), and sterol regulatory element binding protein1 (SREBP1c) and down regulation of ERK expression. Overall, these results demonstrate the potential of REE for development of a drug in the medical treatment of lipid-associated disorders. © The Korean Society of Food Science and Technology 2021.

Entities:  

Keywords:  Adipogenesis; Antioxidant; Lipid-reducing; Lipogenesis; Rosa rugosa

Year:  2021        PMID: 35059236      PMCID: PMC8733064          DOI: 10.1007/s10068-021-01018-3

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  32 in total

1.  Antioxidant activity applying an improved ABTS radical cation decolorization assay.

Authors:  R Re; N Pellegrini; A Proteggente; A Pannala; M Yang; C Rice-Evans
Journal:  Free Radic Biol Med       Date:  1999-05       Impact factor: 7.376

Review 2.  Possible anti-obesity therapeutics from nature--a review.

Authors:  Jong Won Yun
Journal:  Phytochemistry       Date:  2010-08-21       Impact factor: 4.072

3.  Oxidative stress in the metabolic syndrome.

Authors:  K Esposito; M Ciotola; B Schisano; L Misso; G Giannetti; A Ceriello; D Giugliano
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 4.  Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents.

Authors:  Michael I Goran; Geoff D C Ball; Martha L Cruz
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

5.  Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity.

Authors:  Z Wu; E D Rosen; R Brun; S Hauser; G Adelmant; A E Troy; C McKeon; G J Darlington; B M Spiegelman
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

Review 6.  Postprandial hyperlipidemia as a potential residual risk factor.

Authors:  Kazufumi Nakamura; Toru Miyoshi; Kei Yunoki; Hiroshi Ito
Journal:  J Cardiol       Date:  2015-12-29       Impact factor: 3.159

Review 7.  Mitoplasticity: adaptation biology of the mitochondrion to the cellular redox state in physiology and carcinogenesis.

Authors:  Caroline Jose; Su Melser; Giovanni Benard; Rodrigue Rossignol
Journal:  Antioxid Redox Signal       Date:  2012-11-27       Impact factor: 8.401

8.  Antioxidant and anti-obesity activities of Polygonum cuspidatum extract through alleviation of lipid accumulation on 3T3-L1 adipocytes.

Authors:  Dae-Hye Choi; Joon-Hee Han; Keun-Hyung Yu; Min Hong; Sun-Yeop Lee; Ka-Hee Park; Soo-Ung Lee; Tae-Hyung Kwon
Journal:  J Microbiol Biotechnol       Date:  2019-12-09       Impact factor: 2.351

9.  Determination of the relationship between total antioxidant capacity and dietary antioxidant intake in obese patients.

Authors:  P S Besagil; S Çalapkorur; H Şahin
Journal:  Niger J Clin Pract       Date:  2020-04       Impact factor: 0.968

Review 10.  Anti-obesity drugs: past, present and future.

Authors:  R John Rodgers; Matthias H Tschöp; John P H Wilding
Journal:  Dis Model Mech       Date:  2012-09       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.